Approval for a manufacturing site located at vascutek, ltd., scotland, great britain (uk).  Also approval for a valved conduit.  The device, as modified, will be marketed under he trade name on-x ascending aortic prosthesis and is indicated for the replacement of a diseased, damaged, or malfunctioning native or prosthetic heart valve in the aortic position in cases that involve an ascending aortic aneurysm or other associated aortic disease.